SPL Set ID: 3b8f2692-4371-4f1a-95af-b41842131fdd

1 drug(s) with this SPL Set ID

Open DailyMed details

Dextrose DEXTROSE MONOHYDRATE
FRESENIUS KABI USA, LLC FDA Rx Only

10% Dextrose Injection, USP is a sterile, non-pyrogenic solution for fluid replenishment and caloric supply in single dose containers for intravenous administration. The solution contains no bacteriostatic, antimicrobial agent or added buffer and is intended only for use as a single-dose injection. The pH range is 4.0 (3.2 to 6.5) Table 1. Contents and Characteristics of Dextrose Injection 10%, USP *Caloric value calculated on the basis of 3.4 kcal/g of dextrose, hydrous Strength Fill Volume Amount of Dextrose Hydrous per Container kcal* per Container Osmolarity (mOsmol per liter) Dextrose Injection 10%, USP (0.1 grams/mL) 250 mL 25 grams 85 505 500 mL 50 grams 170 505 1000 mL 100 grams 340 505 Dextrose, USP is chemically designated D-glucose, monohydrate (C 6 H 12 O 6 • H 2 O), a hexose sugar freely soluble in water. The molecular weight of dextrose (D-glucose) monohydrate is 198.17. It has the following structural formula: Water for Injection, USP is chemically designated H 2 O. Dextrose is derived from corn. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers ( free flex ® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers. The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration. The container has two ports: one is the administration outlet port for attachment of an intravenous administration set and the other port has a medication site for addition of supplemental medication ([see Instructions for Use ( 2.3 )] ). The primary function of the overwrap is to protect the container from the physical environment. Structural Formula

← Back to search